Prostatic carcinoma metastatic to frontal and cavernous sinuses: a case report  by Lechien, Jérôme Rene et al.
ARTICLE IN PRESS+Model
Braz J Otorhinolaryngol. 2016;xxx(xx):xxx--xxx
www.bjorl.org
Brazilian Journal of
OTORHINOLARYNGOLOGY
CASE REPORT
Prostatic  carcinoma  metastatic  to frontal  and
cavernous sinuses:  a case  report
Carcinoma  prostático  com  metástase  para  seios  frontal  e  cavernoso:  relato
de  caso
Jérôme Rene Lechiena,b,c,∗, Jacques Doyend, Mohamad Khalifea,c, Sven Sausseza,c
a Department  of  Otolaryngology  and  Head  and  Neck  Surgery,  RHMS  Baudour,  EpiCURA  Hospital,  Baudour,  Belgium
b University  of  Mons  (UMONS),  Research  Institute  for  Language  Sciences  and  Technology,  Faculty  of  Psychology,  Mons,  Belgium
c Laboratory  of  Anatomy  and  Cell  Biology,  Faculty  of  Medicine,  Research  Institute  for  Health  Sciences  and  Technology,  University
of Mons  (UMONS),  Mons,  Belgium
d Department  of  Radiology,  RHMS  Baudour,  EpiCURA  Hospital,  Baudour,  BelgiumReceived 18  February  2016;  accepted  16  May  2016
i
s
o
m
c
C
A
l
m
d
e
b
r
just  reported  the  presence  of  a  divergent  strabismus  of  theIntroduction
Primary  malignancies  of  the  nasal  cavity  and  paranasal
sinuses  account  for  0.3%  of  all  head  and  neck  cancers  with
a  proportion  of  tumor  in  sphenoid  and  frontal  sinuses  esti-
mated  to  0.001%.1 Metastatic  lesions  in  these  anatomical
sites  are  even  rarer  since  they  respectively  concern  19%  and
5%  of  all  paranasal  sinuses  metastases.2 Paranasal  metas-
tases  often  come  from  kidney,  lung,  breast  cancers  and
rarely  from  prostatic  carcinomas  since  approximately  13
cases  of  prostatic  metastasis  in  the  nose  and  paranasal
sinuses  have  been  described  in  the  literature.3,4 Nowadays,
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access article under the CC BY license (http://creativecommons.org/lict  seems  that  only  ﬁve  cases  of  prostatic  frontal  metasta-
is  were  reported.3,5--7 In  this  paper,  we  reported  the  case
f  a  patient  with  a  recurrence  of  a  prostatic  carcinoma
anifested  by  concomitant  metastases  in  both  frontal  and
avernous  sinuses.
ase report
 67  year-old  man  was  referred  to  the  Department  of  Oto-
aryngology  for  the  evaluation  of  a  few  days  history  of
onocular  diplopia,  left  facial  and  frontal  pain.  Patient
id  not  report  fever  or  continuous  rhinorrheas.  The  gen-
ral  medical  history  revealed  that  the  patient  had  previously
een  treated  for  a  prostatic  carcinoma  by  surgery,  radiothe-
apy  and  hormonal  therapy.  The  ENT  clinical  examination  haseft  eye  and  frontal  pain  increased  on  palpation.  Concerning
he  nasoﬁbroscopic  examination,  we  did  not  found  rhinor-
hea,  a  nasal  extension  of  the  tumor  and  signs  suggesting  a
 Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
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Figure  3  The  extension  of  the  sinus  frontal  metastasis  with
the loss  of  the  bone  hypointense  zone  showing  a  dural  invasion
(MRI, T1).Figure  1  The  sinus  cavernous  lesion  (MRI,  T2).
omplication  of  a  rhinosinusitis.  The  frontal  mass  seemed
ot  be  complicated  by  a  rhinosinusitis.  A  ﬁrst  physician
uspected  the  diagnosis  of  a  rhinosinusitis  with  a  possi-
le  sinus  cavernous  thrombosis.  Therefore,  he  prescribed
 Magnetic  Resonance  Imaging  (MRI)  and  a  Computed  Tomo-
raphy  (CT)  that  showed  two  focal  lesions,  the  ﬁrst  in  the
eft  cavernous  sinus  and  the  second  in  the  left  frontal  sinus
Figs.  1  and  2).  The  lesion  located  in  the  left  cavernous  sinus
easured  9.9  mm  along  the  axis  and  inﬁltrated  the  left  ante-
ior  clinoid  process.  The  MRI  also  reported  a  T2  hypersignal
oft  tissue  lesion  appearing  in  the  left  frontal  sinus  with  cal-
iﬁcations  and  with  a  gadolinium  enhancement  (34  mm  along
he  axis).  The  signal  abnormality  of  the  medullary  space  of
he  left  frontal  bone,  the  bone  destruction  and  erosion  of
he  posterior  wall  of  frontal  sinus,  and  the  extension  to  the
rontal  cortex  suggested  the  possibility  of  a  metastasis  lesion
igure  2  The  sinus  frontal  lesion  (MRI,  T1).  We  observed
 ≥  2  mm  dural  thickening  (1)  and  nodular  dural  enhancement
2) demonstrating  the  dural  invasion.
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figure  4  CT  images  showing  a  large  frontal  lesion  with  bone
enetration  (1).
Figs.  2--4).  The  whole  body  bone  scintigraphy  has  been
rogrammed  and  reported  multiple  metastases  in  cervical,
orsal,  lumbar  vertebrae  and  in  pleural  compartments.  A
alliative  approach  based  on  the  continuation  of  the  hor-
onal  therapy  (leuprorelin)  was  adopted  given  the  advanced
etastasis  disease.  Moreover,  the  palliative  approach  also
onsisted  of  a  control  of  potential  pain  that  might  arise.
he  patient  died  a  few  months  later  without  showing  exter-
al  mass  on  the  forehead  or  additional  neurological  signs
elated  to  a  potential  frontal  irritation.
iscussionhe  mechanism  of  prostatic  metastases  to  the  paranasal
inuses  involves  a  spread  cells  that  probably  comes
rom  the  vertebral  venous  plexus.5 These  metastases  are
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Prostatic  carcinoma  metastatic  to  frontal  and  cavernous  sin
characterized  by  similar  complaints  to  the  primary  sinuses
carcinoma  i.e.  epistaxis,  facial  pain,  diplopia  and  other
symptoms  due  to  impairments  of  cranial  nerve.7 Although
it  is  described  in  most  published  cases,  our  patient  did  not
report  evident  rhinoscopic  and  radiologic  signs  of  rhinosi-
nusitis  even  if  it  was  the  ﬁrst  diagnosis  hypothesis.  In  the
present  case,  the  diplopia  was  secondary  to  another  metas-
tasis  located  in  cavernous  sinus  leading  to  the  palsy  of  the
third  cranial  nerve.  The  frontal  lesion  had  originated  in
the  bone  posterior  wall  of  the  frontal  sinus  and  simulta-
neously  extended  to  both  frontal  sinus  and  frontal  cortex.
This  clinical  presentation  without  external  mass  and  with
an  extension  to  the  cerebral  anterior  fossa  was  unusual
for  a  frontal  sinus  metastasis.  CT  and  MRI  may  specify  the
extension  of  the  mass  and  whole  body  bone  scintigraphy
or  PET/CT  are  crucial  to  exclude  other  metastases.  Some
studies  suggested  that  malignant  lesions  could  be  diagnosed
mainly  by  the  existence  of  osteolytic  destruction.8 Thus,
the  presence  of  a  soft-tissue  mass  extending  to  the  cere-
bral  anterior  fossa  and  the  bone  lysis  seem  to  be  common
features  of  images  described  in  paranasal  malignancies.8
According  to  MacIntyre  et  al.,  a  ≥  2  ≥  mm  dural  thickening,
the  loss  of  hypointense  zone  (T1  signal  with  gadolinium)
and  nodular  dural  enhancement  could  be  highly  predictive
for  a  dural  invasion9 that  is  observed  in  the  present  case.
By  cons,  it  seems  that  there  is  no  speciﬁc  imaging  sign  to
differentiate  primary  paranasal  cancer  from  metastasis.4
These  speciﬁc  MRI  ﬁndings  that  have  a  high  predictive  value
on  the  malignancy  diagnosis,  are  described  in  our  case.
Except  in  a  single  metastasis  case,  the  role  of  the  func-
tional  endoscopic  sinus  surgery  is  limited  to  the  diagnosis
biopsy  and  the  control  of  the  symptoms  by  a  reduction
of  the  tumor  compression.  Given  the  advanced  metasta-
sis  disease  of  our  patient,  the  biopsy  was  not  considered
to  be  appropriate.  The  treatment  of  frontal  sinus  metas-
tasis  depends  of  the  extension  of  the  disease  and,  when
there  is  an  isolated  metastasis,  it  has  not  been  estab-
lished  in  view  of  the  paucity  of  retrospective  case  studies.
It  seems  that  the  utilization  of  chemotherapy  and  radio-
therapy  report  mixed  results  and  remain  controversial.10
In  this  case,  we  based  the  treatment  on  a  palliative
hormonal  therapy  owing  to  the  hormonal  characteristics
of  the  primary  tumor  and  the  general  metastatic  dis-
ease.  Although  these  lesions  are  rare,  it  seems  that  the
metastatic  disease  in  paranasal  sinuses  is  characterized
by  a  poor  prognosis  leading  to  the  death  within  the  next
months.5,6
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onclusion
oncomitant  metastases  of  the  frontal  and  cavernous
inuses  are  a  rare  condition  that  can  lead  to  a misdiagnosis
f  rhinosinusitis.  In  the  context  of  a  history  of  cancer,  even  if
t  remains  exceptional,  an  imaging  must  be  made  to  precise
he  etiology  of  the  symptoms.  In  the  case  of  frontal  malig-
ancy,  dural  thickening  and  nodular  enhancement  combined
ith  the  loss  of  hypointense  zone  could  be  highly  predictive
or  a  dural  invasion  implying  a  poor  prognosis.
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